If youve been following the news around medications like semaglutide (Ozempic, Wegovy) , tirzepatide (Mounjaro, Zepbound) , and the newer retatrutide (still in clinical trials) , youve probably heard about their impressive results
Results: Acute liraglutide treatment significantly improved insulin, glucose and pyruvate tolerance
The Noom Proactive Health GLP-1 Program is a proactive, science-based approach to health and weight loss
The interaction between these medications and altered GLP-1 levels could affect blood sugar management in ways that need monitoring
Conclusions/interpretation These data highlight that a GLP-1R agonist promotes brown remodelling of WAT in a SIRT1-dependent manner
4 The side effects of semaglutide (GLP-1 RA) So, whats the catch